Search

Search Constraints

You searched for: Author/Creator Correa-Rotter, Ricardo

Search Results

31. Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers. (29th August 2020)

32. Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers. (May 2016)

33. Rationale and population-based prospective cohort protocol for the disadvantaged populations at risk of decline in eGFR (CO-DEGREE). Issue 9 (24th September 2019)

34. Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial. Issue 2 (7th February 2020)

35. Renal Thrombotic Microangiopathy in Proliferative Lupus Nephritis: Risk Factors and Clinical Outcomes. Issue 5 (August 2016)

36. Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial. Issue 9 (25th November 2021)

37. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Issue 10 (30th August 2020)

38. The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Randomized Trial. Issue 12 (December 2021)

39. Urinary neutrophil gelatinase-associated lipocalin predicts graft loss after acute kidney injury in kidney transplant. (February 2014)